Today we're going to take a look at the well-established Illumina Inc (NASDAQ:ILMN). The company's stock saw a double-digit share price rise of over 10% in the past couple of months on the NasdaqGS. As a large-cap stock with high …
I’ve seldom been more right than when I first called ILMN stock a buy, way back in 2013. Then, as now, genetic sequencing had nearly limitless potential to change medicine as we know it, but then, as opposed to now, Ilumina was …
Illumina Inc. (ILMN) announced Tuesday morning that it has entered into ... Illumina gapped open sharply higher this morning and is now up 12.22 at $239.28. The stock has broken out of over a 1-month trading range and has set a new …
Illumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday ... Shares of Illumina have recently been trading up over 9% at $179.94. The company’s stock has a consensus analyst price target of $198.21 and a 52 …
Illumina (NASDAQ:ILMN) shareholders already knew there was much to like about the company's performance in 2017. The stock soared nearly 71% last year, riding a wave of momentum generated by the launch of its powerful new gene …
The stock initially indicated up 5% after hours only to reverse course during the call. The analyst stated "We still think ILMN continues to penetrate potentially large markets while also enabling broader adoption of Genomics 2.0 …
On January 05 th, 2018, research firm BTIG Research initiated a 'Neutral' rating on the Company's stock. Get access to …
Illumina Inc. ILMN reported adjusted earnings per share (EPS ... Illumina's adjusted gross margin (considering stock-based compensation as regular expense) came in at 72.5%, reflecting a contraction of 70 basis points (bps) year over year, …
Illumina Inc.(NASDAQ: ILMN) reported adjusted earnings of 57 cents per share ... Illumina's adjusted gross margin (considering stock-based compensation as regular expense) came in at 70.4%, up 130 basis points (bps) year over …